Daily as of 3 Nov 16:00 ET
- Price
- below both $1.12 vs 50 $1.58 / 200 $1.97
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Sep 2026 · projected 12 bars out
ALLO | Allogene TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$1.12
+$0.03 (+2.75%)
Allogene Therapeutics (ALLO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $1.18 vs 50 $1.88 / 200 $2.82
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- below both $1.12 vs 50 $1.34 / 200 $1.78
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 2 Jun 2026 bar 2 · projected 19 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Sep 2026 | 💀Death flat | daily | 12 bars out | Not tested |
| 2 Jun 2026 | 💀Death | 4-hour | 19 bars out | 1 bar cross test |
| 24 Dec 2025 | 🟨Golden flat | daily | 17 bars out | 4 bar cross test |
| 9 Oct 2025 | 🟨Golden | 4-hour | 26 bars out | — |
| 22 Nov 2024 | 💀Death | 4-hour | 17 bars out | — |
About ALLO
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall